Anti-asthma drugs drive pharma market growth
Source: Times Of India Respiratory therapies led the growth during Jan in the pharma market, which seemed to have started the year with a bang, growing nearly 8% to Rs 17,937 crore. Anti-asthma drugs (Foracort and Budecort) continued to post a double-digit growth each during the month, pointing to our struggle with growing pollution levels […]